首页> 外文OA文献 >A mathematical model for optimizing the indications of liver transplantation in patients with hepatocellular carcinoma
【2h】

A mathematical model for optimizing the indications of liver transplantation in patients with hepatocellular carcinoma

机译:优化肝细胞癌患者肝移植适应证的数学模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abstract Background The criteria for organ sharing has developed a system that prioritizes liver transplantation (LT) for patients with hepatocellular carcinoma (HCC) who have the highest risk of wait-list mortality. In some countries this model allows patients only within the Milan Criteria (MC, defined by the presence of a single nodule up to 5 cm, up to three nodules none larger than 3 cm, with no evidence of extrahepatic spread or macrovascular invasion) to be evaluated for liver transplantation. This police implies that some patients with HCC slightly more advanced than those allowed by the current strict selection criteria will be excluded, even though LT for these patients might be associated with acceptable long-term outcomes. Methods We propose a mathematical approach to study the consequences of relaxing the MC for patients with HCC that do not comply with the current rules for inclusion in the transplantation candidate list. We consider overall 5-years survival rates compatible with the ones reported in the literature. We calculate the best strategy that would minimize the total mortality of the affected population, that is, the total number of people in both groups of HCC patients that die after 5 years of the implementation of the strategy, either by post-transplantation death or by death due to the basic HCC. We illustrate the above analysis with a simulation of a theoretical population of 1,500 HCC patients with tumor size exponentially. The parameter λ obtained from the literature was equal to 0.3. As the total number of patients in these real samples was 327 patients, this implied in an average size of 3.3 cm and a 95% confidence interval of [2.9; 3.7]. The total number of available livers to be grafted was assumed to be 500. Results With 1500 patients in the waiting list and 500 grafts available we simulated the total number of deaths in both transplanted and non-transplanted HCC patients after 5 years as a function of the tumor size of transplanted patients. The total number of deaths drops down monotonically with tumor size, reaching a minimum at size equals to 7 cm, increasing from thereafter. With tumor size equals to 10 cm the total mortality is equal to the 5 cm threshold of the Milan criteria. Conclusion We concluded that it is possible to include patients with tumor size up to 10 cm without increasing the total mortality of this population.
机译:摘要背景器官共享的标准已经开发出了一种系统,该系统优先考虑等待死亡风险最高的肝细胞癌(HCC)患者的肝移植(LT)。在某些国家/地区,此模型仅允许患者符合米兰标准(MC,定义为单个结节最大5厘米,最多三个结节不大于3厘米,没有肝外扩散或大血管侵犯的证据)进行肝移植评估。该警察暗示,将排除一些比当前严格选择标准所允许的病情稍高的HCC患者,即使这些患者的LT可能与可接受的长期预后相关。方法我们提出一种数学方法来研究放宽MC对不符合当前纳入候选移植名单规则的HCC患者的后果。我们认为总体5年生存率与文献报道的相符。我们计算了最佳策略,该策略将使受影响人群的总死亡率(即,实施该策略的5年后死亡的两组HCC患者的总死亡率)降至最低,无论是通过移植后死亡还是通过因基本肝癌死亡。我们通过模拟1,500名HCC患者的肿瘤大小以指数方式模拟来说明上述分析。从文献中获得的参数λ等于0.3。由于这些真实样本中的患者总数为327名患者,这意味着平均大小为3.3厘米,95%的置信区间为[2.9; 3.7]。假设要移植的可用肝总数为500。结果在等待名单中有1500例患者和可用的500例移植物中,我们模拟了5年后移植和未移植HCC患者的死亡总数与移植患者的肿瘤大小。死亡总数随肿瘤大小单调下降,在等于7厘米的大小处达到最小值,此后增加。如果肿瘤大小等于10 cm,则总死亡率等于Milan标准的5 cm阈值。结论我们得出的结论是,可以将肿瘤大小最大为10 cm的患者包括在内,而不会增加该人群的总死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号